Skip to main content
Smart Investors Daily
Virpax Pharmaceuticals, Inc. logo

NASDAQ · VRPX

Virpax Pharmaceuticals, Inc.

Healthcare · Biotechnology

$0.01

Up+$0.00 (+0.00%)

Updated Sep 27, 2026, 4:48 AM

SID Score

2.6/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
26.09K
P/E ratio
-0.01
Dividend yield
0.00%
52-week range
$0.00 – $0.48
Volume
261
Avg. volume
1.9K

Price performance

VRPX price history

1M range · 0 trading sessions · Daily adjusted prices

VRPX does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VRPX news

The latest Smart Investors Daily articles mentioning VRPX.

VRPX research

Overview

Company profile and research snapshot.

Company profile

VIRPAX PHARMS INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$3.00
Implied upside
—
Analysts
—
VRPX recent ratings
DateFirmRatingTarget
Oct 9, 2024Maxim GroupHold—
Jul 19, 2024Maxim GroupBuy—
May 22, 2024Maxim GroupHold—
Jun 9, 2022Maxim GroupBuy—
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.